Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Multicenter clinical trial indicates alendronate effective in osteoporotic fracture prevention

May 31, 1996

PKC pathway activation may have therapeutic significance in bone disease management

May 31, 1996

New contraceptives reported by Akzo Nobel

May 24, 1996

Forskolin studied as rescue therapy for impotence

May 24, 1996

Nitroglycerin gel enhances erectile function in healthy males

May 24, 1996

Clomipramine for treatment of premature ejaculation

May 24, 1996

Losartan for treatment of erectile dysfunction

May 24, 1996

Vasomax completes phase II in Germany

May 24, 1996

MacroChem's erectile dysfunction therapy moves to phase I/II in U.S.

May 24, 1996

Takeda claims antidiabetic and hypolipidemic agents

May 24, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...
ADCs, multispecific antibodies anchor $10B Pfizer-Innovent deal
BioWorld
Pfizer Inc. is paying Innovent Biologics Co. Ltd. $650 million up front and up to $9.85 billion in milestones, plus royalties, to collaborate across 12 early...